Schizophrenia: Susceptibility genes and oligodendroglial and myelin related abnormalities

Frontiers in Cellular Neuroscience

Volumn 8, Issue JAN, 2014, Pages

  Roussos, Panos ^a,b   Haroutunian, Vahram ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Disconnectivity; GWAS; Node of Ranvier; Polygenic; Systems biology

Indexed keywords

ANKYRIN; AXONIN 1; CLAUDIN 11; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; MYELIN; MYELIN AND LYMPHOCYTE PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NERVE CELL ADHESION MOLECULE; NEU DIFFERENTIATION FACTOR; NEUROTRANSMITTER; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PERIPHERAL MYELIN PROTEIN 22; PROTEIN TYROSINE PHOSPHATASE; PROTEOLIPID PROTEIN; TRANSCRIPTION FACTOR SOX10; TRANSFERRIN;

CNTNAP2 GENE; DISRUPTED IN SCHIZOPHRENIA1 GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MYELINATION; NEUROFACIN GENE; NONHUMAN; OLIGODENDROGLIA; RANVIER NODE; RETICULON 4 RECEPTOR GENE; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

EID: 84892992324     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00005     Document Type: Review

References (79)

1. Aberg, K., Saetre, P., Jareborg, N., and Jazin, E. (2006a). Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 103, 7482-7487. doi: 10.1073/pnas.0601213103
2. Aberg, K., Saetre, P., Lindholm, E., Ekholm, B., Pettersson, U., Adolfsson, R., et al. (2006b). Human QKI, a new candidate gene for schizophrenia involved in myelination. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 84-90. doi: 10.1002/ajmg.b.30243
3. Agim, Z. S., Esendal, M., Briollais, L., Uyan, O., Meschian, M., Martinez, L. A., et al. (2013). Discovery, validation and characterization of Erbb4 and Nrg1 haplotypes using data from three genome-wide association studies of schizophrenia. PLoS ONE 8:e53042. doi: 10.1371/journal.pone.0053042
4. Allen, N. J., and Barres, B. A. (2009). Neuroscience: glia-more than just brain glue. Nature 457, 675-677. doi: 10.1038/457675a
5. Athanasiu, L., Mattingsdal, M., Kahler, A. K., Brown, A., Gustafsson, O., Agartz, I., et al. (2010). Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J. Psychiatr. Res. 44, 748-753. doi: 10.1016/j.jpsychires.2010.02.002
6. Ayalew, M., Le-Niculescu, H., Levey, D. F., Jain, N., Changala, B., Patel, S. D., et al. (2012). Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol. Psychiatry 17, 887-905. doi: 10.1038/mp.2012.37
7. Barley, K., Dracheva, S., and Byne, W. (2009). Subcortical oligodendrocyte-and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder. Schizophr. Res. 112, 54-64. doi: 10.1016/j.schres.2009.04.019
8. Bartzokis, G. (2011). Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments. Front. Biosci. (Landmark Ed) 16:2695-2733. doi: 10.2741/3881
9. Budel, S., Padukkavidana, T., Liu, B. P., Feng, Z., Hu, F., Johnson, S., et al. (2008). Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J. Neurosci. 28, 13161-13172. doi: 10.1523/JNEUROSCI.3828-08.2008
10. Buxbaum, J. D., Georgieva, L., Young, J. J., Plescia, C., Kajiwara, Y., Jiang, Y., et al. (2008). Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Mol. Psychiatry 13, 162-172. doi: 10.1038/sj.mp.4001991
11. Chen, M. S., Huber, A. B., Van Der Haar, M. E., Frank, M., Schnell, L., Spillmann, A. A., et al. (2000). Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434-439. doi: 10.1038/35000219
12. Chong, V. Z., Thompson, M., Beltaifa, S., Webster, M. J., Law, A. J., and Weickert, C. S. (2008). Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr. Res. 100, 270-280. doi: 10.1016/j.schres.2007.12.474
13. Chubb, J. E., Bradshaw, N. J., Soares, D. C., Porteous, D. J., and Millar, J. K. (2008). The DISC locus in psychiatric illness. Mol. Psychiatry 13, 36-64. doi: 10.1038/sj.mp.4002106
14. Cruz, D. A., Weaver, C. L., Lovallo, E. M., Melchitzky, D. S., and Lewis, D. A. (2009). Selective alterations in postsynaptic markers of chandelier cell inputs to cortical pyramidal neurons in subjects with schizophrenia. Neuropsychopharmacology 34, 2112-2124. doi: 10.1038/npp.2009.36
15. Debono, R., Topless, R., Markie, D., Black, M. A., and Merriman, T. R. (2012). Analysis of the DISC1 translocation partner (11q14.3) in genetic risk of schizophrenia. Genes Brain Behav. 11, 859-863. doi: 10.1111/j.1601-183X.2012.00832.x
16. Dracheva, S., Davis, K. L., Chin, B., Woo, D. A., Schmeidler, J., and Haroutunian, V. (2006). Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiol. Dis. 21, 531-540. doi: 10.1016/j.nbd.2005.08.012
17. Drerup, C. M., Wiora, H. M., Topczewski, J., and Morris, J. A. (2009). Disc1 regulates foxd3 and sox10 expression, affecting neural crest migration and differentiation. Development 136, 2623-2632. doi: 10.1242/dev.030577
18. Fitzsimmons, J., Kubicki, M., and Shenton, M. E. (2013). Review of functional and anatomical brain connectivity findings in schizophrenia. Curr. Opin. Psychiatry 26, 172-187. doi: 10.1097/YCO.0b013e32835d9e6a
19. Friedman, J. I., Vrijenhoek, T., Markx, S., Janssen, I. M., Van Der Vliet, W. A., Faas, B. H., et al. (2008). CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol. Psychiatry 13, 261-266. doi: 10.1038/sj.mp.4002049
20. Georgieva, L., Moskvina, V., Peirce, T., Norton, N., Bray, N. J., Jones, L., et al. (2006). Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 103, 12469-12474. doi: 10.1073/pnas.0603029103
21. Goudriaan, A., De Leeuw, C., Ripke, S., Hultman, C. M., Sklar, P., Sullivan, P. F., et al. (2013). Specific glial functions contribute to schizophrenia susceptibility. Schizophr. Bull. doi: 10.1093/schbul/sbt109 [Epub ahead of print].
22. Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., et al. (2001). Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 98, 4746-4751. doi: 10.1073/pnas.081071198
23. Hall, J., Whalley, H. C., Job, D. E., Baig, B. J., McIntosh, A. M., Evans, K. L., et al. (2006). A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat. Neurosci. 9, 1477-1478. doi: 10.1038/nn1795
24. Harrison, P. J., and Law, A. J. (2006). Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 60, 132-140. doi: 10.1016/j.biopsych.2005.11.002
25. Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E., and Weinberger, D. R. (2004). Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatry 9, 299-307. doi: 10.1038/sj.mp.4001434
26. Insel, T. R. (2010). Rethinking schizophrenia. Nature 468, 187-193. doi: 10.1038/nature09552
27. Ji, W., Li, T., Pan, Y., Tao, H., Ju, K., Wen, Z., et al. (2013). CNTNAP2 is significantly associated with schizophrenia and major depression in the Han Chinese population. Psychiatry Res. 207, 225-228. doi: 10.1016/j.psychres.2012.09.024
28. Katsel, P., Davis, K. L., and Haroutunian, V. (2005). Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study. Schizophr. Res. 79, 157-173. doi: 10.1016/j.schres.2005.06.007
29. Katsel, P., Tan, W., Abazyan, B., Davis, K. L., Ross, C., Pletnikov, M. V., et al. (2011). Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes. Schizophr. Res. 130, 238-249. doi: 10.1016/j.schres.2011.04.021
30. Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K. K., Holmans, P., et al. (2009). Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 18, 1497-1503. doi: 10.1093/hmg/ddp043
31. Konrad, A., Vucurevic, G., Musso, F., Stoeter, P., Dahmen, N., and Winterer, G. (2009). ErbB4 genotype predicts left frontotemporal structural connectivity in human brain. Neuropsychopharmacology 34, 641-650. doi: 10.1038/npp.2008.112
32. Konrad, A., and Winterer, G. (2008). Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon? Schizophr. Bull. 34, 72-92. doi: 10.1093/schbul/sbm034
33. Law, A. J., Kleinman, J. E., Weinberger, D. R., and Weickert, C. S. (2007). Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum. Mol. Genet. 16, 129-141. doi: 10.1093/hmg/ddl449
34. Law, A. J., Lipska, B. K., Weickert, C. S., Hyde, T. M., Straub, R. E., Hashimoto, R., et al. (2006). Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc. Natl. Acad. Sci. U.S.A. 103, 6747-6752. doi: 10.1073/pnas.0602002103
35. Li, D., Feng, G., and He, L. (2009). Case-control study of association between the functional candidate gene ERBB3 and schizophrenia in Caucasian population. World J. Biol. Psychiatry 10, 595-598. doi: 10.1080/15622970903304442
36. Liu, X., Qin, W., He, G., Yang, Y., Chen, Q., Zhou, J., et al. (2005). A family-based association study of the MOG gene with schizophrenia in the Chinese population. Schizophr. Res. 73, 275-280. doi: 10.1016/j.schres.2004.07.018
37. Maeno, N., Takahashi, N., Saito, S., Ji, X., Ishihara, R., Aoyama, N., et al. (2007). Association of SOX10 with schizophrenia in the Japanese population. Psychiatr. Genet. 17, 227-231. doi: 10.1097/YPG.0b013e3280ae6cd8
38. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi-Gulyas, E., Eberlin, M. N., et al. (2009a). Proteomic analysis of dorsolateral prefrontal cortex indicates the involvement of cytoskeleton, oligodendrocyte, energy metabolism and new potential markers in schizophrenia. J. Psychiatr. Res. 43, 978-986. doi: 10.1016/j.jpsychires.2008.11.006
39. Martins-de-Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Marangoni, S., Novello, J. C., et al. (2009b). Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J. Neural. Transm. 116, 275-289. doi: 10.1007/s00702-008-0156-y
40. Matthews, P. R., Eastwood, S. L., and Harrison, P. J. (2012). Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia. PLoS ONE 7:e38211. doi:10.1371/journal.pone.0038211
41. McCullumsmith, R. E., Gupta, D., Beneyto, M., Kreger, E., Haroutunian, V., Davis, K. L., et al. (2007). Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophr. Res. 90, 15-27. doi: 10.1016/j.schres.2006.11.017
42. McIntosh, A. M., Moorhead, T. W., Job, D., Lymer, G. K., Munoz Maniega, S., Mckirdy, J., et al. (2008). The effects of a neuregulin 1 variant on white matter density and integrity. Mol. Psychiatry 13, 1054-1059. doi: 10.1038/sj.mp.4002103
43. Millar, J. K., Wilson-Annan, J. C., Anderson, S., Christie, S., Taylor, M. S., Semple, C. A., et al. (2000). Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet. 9, 1415-1423. doi: 10.1093/hmg/9.9.1415
44. Nakata, K., Lipska, B. K., Hyde, T. M., Ye, T., Newburn, E. N., Morita, Y., et al. (2009). DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc. Natl. Acad. Sci. U.S.A. 106, 15873-15878. doi: 10.1073/pnas.0903413106
45. Nave, K. A. (2010). Myelination and support of axonal integrity by glia. Nature 468, 244-252. doi: 10.1038/nature09614
46. Norton, N., Moskvina, V., Morris, D. W., Bray, N. J., Zammit, S., Williams, N. M., et al. (2006). Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 96-101. doi: 10.1002/ajmg.b.30236
47. Novak, G., Kim, D., Seeman, P., and Tallerico, T. (2002). Schizophrenia and Nogo: elevated mRNA in cortex, and high prevalence of a homozygous CAA insert. Brain Res. Mol. Brain Res. 107, 183-189. doi: 10.1016/S0169-328X(02)00492-8
48. Peirce, T. R., Bray, N. J., Williams, N. M., Norton, N., Moskvina, V., Preece, A., et al. (2006). Convergent evidence for 2′,3′-cyclic nucleotide 3′-phosphodiesterase as a possible susceptibility gene for schizophrenia. Arch. Gen. Psychiatry 63, 18-24. doi: 10.1001/archpsyc.63.1.18
49. Poliak, S., and Peles, E. (2003). The local differentiation of myelinated axons at nodes of Ranvier. Nat. Rev. Neurosci. 4, 968-980. doi: 10.1038/nrn1253
50. Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J. T., Griffin, J. L., et al. (2004). Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 9, 684-697, 643. doi: 10.1038/sj.mp.4001511
51. Qin, W., Gao, J., Xing, Q., Yang, J., Qian, X., Li, X., et al. (2005). A family-based association study of PLP1 and schizophrenia. Neurosci. Lett. 375, 207-210. doi: 10.1016/j.neulet.2004.11.013
52. Qu, M., Yue, W., Tang, F., Wang, L., Han, Y., and Zhang, D. (2008). Polymorphisms of Transferrin gene are associated with schizophrenia in Chinese Han population. J. Psychiatr. Res. 42, 877-883. doi: 10.1016/j.jpsychires.2007.10.005
53. Rastogi, A., Zai, C., Likhodi, O., Kennedy, J. L., and Wong, A. H. (2009). Genetic association and post-mortem brain mRNA analysis of DISC1 and related genes in schizophrenia. Schizophr. Res. 114, 39-49. doi: 10.1016/j.schres.2009.06.019
54. Ratta-Apha, W., Hishimoto, A., Mouri, K., Shiroiwa, K., Sasada, T., Yoshida, M., et al. (2013). Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain. Neurosci. Res. 77, 222-227. doi: 10.1016/j.neures.2013.08.010
55. Ren, Y., Wang, H., and Xiao, L. (2013). Improving myelin/oligodendrocyte-related dysfunction: a new mechanism of antipsychotics in the treatment of schizophrenia? Int. J. Neuropsychopharmacol. 16, 691-700. doi: 10.1017/S1461145712001095
56. Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J. L., Kahler, A. K., Akterin, S., et al. (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159. doi: 10.1038/ng.2742
57. Ross, S. E., Greenberg, M. E., and Stiles, C. D. (2003). Basic helix-loop-helix factors in cortical development. Neuron 39, 13-25. doi: 10.1016/S0896-6273(03)00365-9
58. Roussos, P. (2012). Transcription factor 4 as an important determinant of gating function in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 109, 5915-5916. doi: 10.1073/pnas.1203675109
59. Roussos, P., Giakoumaki, S. G., Adamaki, E., and Bitsios, P. (2011). The influence of schizophrenia-related neuregulin-1 polymorphisms on sensorimotor gating in healthy males. Biol. Psychiatry 69, 479-486. doi: 10.1016/j.biopsych.2010.09.009
60. Roussos, P., Katsel, P., Davis, K. L., Bitsios, P., Giakoumaki, S. G., Jogia, J., et al. (2012a). Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch. Gen. Psychiatry 69, 7-15. doi: 10.1001/archgenpsychiatry.2011.110
61. Roussos, P., Katsel, P., Davis, K. L., Siever, L. J., and Haroutunian, V. (2012b). A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch. Gen. Psychiatry 69, 1205-1213. doi: 10.1001/archgenpsychiatry.2012.704
62. Saetre, P., Agartz, I., De Franciscis, A., Lundmark, P., Djurovic, S., Kahler, A., et al. (2008). Association between a disrupted-in-schizophrenia 1 (DISC1) single nucleotide polymorphism and schizophrenia in a combined Scandinavian case-control sample. Schizophr. Res. 106, 237-241. doi: 10.1016/j.schres.2008.08.024
63. Sequeira, P. A., Martin, M. V., and Vawter, M. P. (2012). The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol. Dis. 45, 23-36. doi: 10.1016/j.nbd.2011.03.001
64. Silberberg, G., Darvasi, A., Pinkas-Kramarski, R., and Navon, R. (2006). The involvement of ErbB4 with schizophrenia: association and expression studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 142-148. doi: 10.1002/ajmg.b.30275
65. Sklar, P., Ripke, S., Scott, L. J., Andreassen, O. A., Cichon, S., Craddock, N., et al. (2011). Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43, 977-983. doi: 10.1038/ng.943
66. Song, W., Li, W., Feng, J., Heston, L. L., Scaringe, W. A., and Sommer, S. S. (2008). Identification of high risk DISC1 structural variants with a 2% attributable risk for schizophrenia. Biochem. Biophys. Res. Commun. 367, 700-706. doi: 10.1016/j.bbrc.2007.12.117
67. Sprooten, E., Sussmann, J. E., Moorhead, T. W., Whalley, H. C., Ffrench-Constant, C., Blumberg, H. P., et al. (2011). Association of white matter integrity with genetic variation in an exonic DISC1 SNP. Mol. Psychiatry 16, 685, 688-689. doi: 10.1038/mp.2011.15
68. Stefanis, N. C., Trikalinos, T. A., Avramopoulos, D., Smyrnis, N., Evdokimidis, I., Ntzani, E. E., et al. (2007). Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level. Biol. Psychiatry 62, 784-792. doi: 10.1016/j.biopsych.2006.11.015
69. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., et al. (2002). Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892. doi: 10.1086/342734
70. Takahashi, N., Sakurai, T., Davis, K. L., and Buxbaum, J. D. (2011). Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Prog. Neurobiol. 93, 13-24. doi: 10.1016/j.pneurobio.2010.09.004
71. Tan, W., Wang, Y., Gold, B., Chen, J., Dean, M., Harrison, P. J., et al. (2007). Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J. Biol. Chem. 282, 24343-24351. doi: 10.1074/jbc.M702953200
72. Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B., et al. (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805. doi: 10.1016/S0140-6736(03)14289-4
73. Voineskos, A. N., De Luca, V., Bulgin, N. L., Van Adrichem, Q., Shaikh, S., Lang, D. J., et al. (2008). A family-based association study of the myelin-associated glycoprotein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase genes with schizophrenia. Psychiatr. Genet. 18, 143-146. doi: 10.1097/YPG.0b013e3282fa1874
74. Wan, C., Yang, Y., Feng, G., Gu, N., Liu, H., Zhu, S., et al. (2005). Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population. Neurosci. Lett. 388, 126-131. doi: 10.1016/j.neulet.2005.06.051
75. Wang, K. S., Liu, X. F., and Aragam, N. (2010). A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder. Schizophr. Res. 124, 192-199. doi: 10.1016/j.schres.2010.09.002
76. Weickert, C. S., Tiwari, Y., Schofield, P. R., Mowry, B. J., and Fullerton, J. M. (2012). Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity. Transl. Psychiatry 2, e104. doi: 10.1038/tp.2012.25
77. Yang, Y. F., Qin, W., Shugart, Y. Y., He, G., Liu, X. M., Zhou, J., et al. (2005). Possible association of the MAG locus with schizophrenia in a Chinese Han cohort of family trios. Schizophr. Res. 75, 11-19. doi: 10.1016/j.schres.2004.11.013
78. Yuan, A., Yi, Z., Sun, J., Du, Y., Yu, T., Zhang, C., et al. (2012a). Effect of SOX10 gene polymorphism on early onset schizophrenia in Chinese Han population. Neurosci. Lett. 521, 93-97. doi: 10.1016/j.neulet.2012.05.040
79. Yuan, A., Yi, Z., Wang, Q., Sun, J., Li, Z., Du, Y., et al. (2012b). ANK3 as a risk gene for schizophrenia: new data in Han Chinese and meta analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B, 997-1005. doi: 10.1002/ajmg.b.32112